Report Summary

The global cell culture market is estimated to be USD 19.6 billion in 2019 and is anticipated to grow at a CAGR of 11.8% during the forecast period. Since biotechnology has gained a central importance for the R&D of newer healthcare and biological applications, living cells and tissues have become central to any and all research activity.

Therefore, this market and its applications in the field of molecular biological R&D have remained and are expected to remain a critical factor for any further development. With the advent of genetic engineering, recombinant DNA technology, genomic and proteomic profiling, the cell culture techniques have become indispensible.

Usage of cell cultures has increased to an extent where traditional small-scale production and handling of cultures falling short for the increasing demand. This has encouraged the development of automated large-scale cell culture systems which are capable of producing high throughput cell cultures of excellent purity and in larger quantities. The continued development of cell culture techniques and applications has poised this market to expect a steady and substantial growth through to 2026.

Know more about this report: request for sample pages

Product Outlook

Product segments in this market include culture systems, incubators, pipetting instruments, biosafety and cryostorage equipment. Further classification of culture systems includes culture plates, culture bags, T-flasks, roller bottles, bioreactors and centrifuges.

Culture Systems are expected to have the largest market share as they are the integral part for the cell culture process. Moreover, with advancement in the development of spheroid and complex bioreactors and with the introduction of 3D cell culture, this segment has gained a significant momentum.

These factors along with the culture systems which include robotic automated liquid handling instruments and sophisticated separator systems are more expensive as opposed to the other segments, it is expected that cell culture system segment will continue to dominate this market throughout the forecast period. With the seemingly estimated introduction of extremely automated robotic laboratory equipment, this segment is also poised to grow at a considerable CAGR through to 2026.

Cell Culture Market Report Scope

Product Outlook Applications Outlook Consumables Outlook Regional Outlook Pipetting instruments

Centrifuges

Biosafety instruments

Culture systems

Incubators

Cryostorage equipment Drug development

Tissue culture & engineering

Gene therapy

Biopharmaceuticals

Toxicity testing

Vaccine production Sera (Fetal bovine serum and others)

Media (Minimum essential, RPMI 1640, DMEM/F-12, F-10, Basel medium eagle, Insect and others)

Reagents (Culture albumin and others) North America (U.S., Canada)

Europe (Germany, UK, France, Italy, Spain, Belgium, Russia, Netherlands)

Asia-Pacific (China, Japan, India, Australia, Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines)

Latin America (Brazil, Mexico, Argentina)

Middle East and Africa (UAE, Saudi Arabia, South Africa)

Know more about this report: request for sample pages

Applications Outlook

Cell culture techniques find applications in the fields of biotech research and molecular studies, cancer study, gene therapy, toxicity testing, tissue engineering, drug development, manufacturing of biopharmaceuticals and production of vaccines.

A thorough study of the market reveals that the highest revenue generated in the market through application of cell culturing is in the fields of manufacturing biopharmaceuticals followed by production of vaccines. A very important factor contributing to this dominance is the fact that a mass culture of animal cells, especially mammalian, is an elementary step for the fabrication of biotechnological products, primarily viral vaccines.

Owing to the innovations in genetic engineering there has been a significant increase in the usage of protein based biopharmaceuticals. Their production is greatly dependent on the protein expression systems derived from mammalian cell cultures and construction of high yielding cell lines. This recently developed application of cell cultures in the biopharmaceutical segment is responsible for most of the revenue generated from this segment and is also expected to be the primary cause for the same throughout the forecast period.

Consumable Outlook

Cell culture consumable market section consists of cell culture media, sera as well as reagent markets. The greatest development amongst these sections is being observed in the media market. The market is driven by enhancing upright assimilation, development of the biopharmaceutical market owing to boosting need for different media choices.

Cell culture media creates the biggest share (by volume) for any kind of culture preparation. As contrasted to typical market rates of sera as well as reagents, media is loosely prices but have high consumption value. Expanding need for culturing in cytological projects, it is anticipated that the section will certainly witness significant growth over the projected period.

Regional Outlook

The largest share of revenue generated globally was accounted for by North America in 2019. Owing to the introduction and progress of automated cell culture techniques and increasing usage of stem cell therapy in the region, cell culture finds most application in the U.S. and Canadian life science laboratories. In the U.S. alone, the cell culture automation for cell-based assays such as induced pluripotent stem cell research, cellular expression, culturing of monoclonal antibodies (MaBs) and cryobanking accounted for about a third of the revenue generated.

Development of automatic single cell examination and segregation systems in Asia Pacific region, especially Japan, for advanced research in stem cell therapies is also expected to fuel the market during the foreseeable future and account for the expected growth of the Asia Pacific region in the coming years.

Competitive Outlook

Key participants of the market include Thermo Fisher Scientific, Sartorius, Merck, Sigma-Aldrich Co., LLC, Promocell, Lonza, Eppendorf and Becton, Dickinson & Company.

Due to the advanced developments in bioreactors, the companies are also involved in the introduction and improvement of 3D cell culture techniques which are a step up from the conventional 2D cell cultures. Three-dimensional cell colonies which are obtained from 3D cultures are more accurate models of in vivo cells and it is expected that there development will further fuel market growth.